Search research articles
Contact Us
Filters
Showing results (291-300 of 315) with videos related to
Page
of 32
Sort By:
The Canadian Journal of Urology
|
June 13, 2015
Three year results of the prostatic urethral L.I.F.T. study
Claus G Roehrborn, Daniel B Rukstalis, Jack Barkin, et al.
Cancer
|
March 11, 2020
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
Celestia S Higano, Andrew J Armstrong, Oliver Sartor, et al.
The New England Journal of Medicine
|
June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Mary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
The Journal of Urology
|
August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial
K Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D Shore, Matthew P Morrow, Trevor McMullan, et al.
The Lancet. Oncology
|
May 13, 2024
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 315) with videos related to
Sort By:
Page
of 32
The Canadian Journal of Urology
|
June 13, 2015
Three year results of the prostatic urethral L.I.F.T. study
Claus G Roehrborn, Daniel B Rukstalis, Jack Barkin, et al.
Cancer
|
March 11, 2020
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
Celestia S Higano, Andrew J Armstrong, Oliver Sartor, et al.
The New England Journal of Medicine
|
June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Mary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Prostate Cancer and Prostatic Diseases
|
March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
The Journal of Urology
|
August 26, 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial
K Kent Chevli, Neal D Shore, Andrew Trainer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens
Neal D Shore, Matthew P Morrow, Trevor McMullan, et al.
The Lancet. Oncology
|
May 13, 2024
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer
Soumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.
Page
of 32